{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02192749",
      "OrgStudyIdInfo": {
        "OrgStudyId": "TBS-UCMSC-ASD001"
      },
      "Organization": {
        "OrgFullName": "Translational Biosciences",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism",
      "OfficialTitle": "Open, Prospective Trial of Treatment of Autism Spectrum Disorders (ASD) Using Intravenous Infusion of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC)"
    },
    "StatusModule": {
      "StatusVerifiedDate": "October 2017",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "July 2014"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "August 2017",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "August 2017",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "July 12, 2014",
      "StudyFirstSubmitQCDate": "July 15, 2014",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "July 17, 2014",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "October 12, 2017",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "October 13, 2017",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Translational Biosciences",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "Allogeneic (not from the subject) human umbilical cord tissue-derived stem cells administered intravenously (IV) in a series of 4 infusions every 3 months over the course of one year is safe and will induce a therapeutic effect in autism patients."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Autism"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "autism",
          "umbilical cord",
          "mesenchymal",
          "stem cells"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "20",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Umbilical cord mesenchymal stem cells",
            "ArmGroupType": "Experimental",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Umbilical cord mesenchymal stem cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Umbilical cord mesenchymal stem cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Umbilical cord mesenchymal stem cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Number of participants with adverse events",
            "PrimaryOutcomeTimeFrame": "89 weeks"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Number of participants with a change in disability as measured by the Autism Treatment Evaluation Checklist (ATEC)",
            "SecondaryOutcomeTimeFrame": "13 weeks, 25 weeks, 37 weeks, 49 weeks, 89 weeks"
          },
          {
            "SecondaryOutcomeMeasure": "Number of participants with a change in disability as measured by the Childhood Autism Rating Scale (CARS)",
            "SecondaryOutcomeTimeFrame": "13 weeks, 25 weeks, 37 weeks, 49 weeks, 89 weeks"
          },
          {
            "SecondaryOutcomeMeasure": "Change from baseline macrophage-derived chemokine (MDC)",
            "SecondaryOutcomeTimeFrame": "13 weeks, 25 weeks, 37 weeks, 49 weeks, 89 weeks"
          },
          {
            "SecondaryOutcomeMeasure": "Change from baseline thymus and activation-regulated chemokine (TARC)",
            "SecondaryOutcomeTimeFrame": "13 weeks, 25 weeks, 37 weeks, 49 weeks, 89 weeks"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nMale or Female\nAges 6 to 16\nDiagnostic and Statistical Manual of Mental Disorders (DSM IV) diagnosis of autism confirmed by Autism Diagnostic Observation Schedule (ADOS) and/or Autism Diagnostic Interview-Revised (ADI-R)\nNo anticipated changes in treatment for the study duration (e.g., diet, nutrients)\nNo additional biomedical treatments started 6 weeks prior to enrollment\nNo changes in dietary management for 3 months prior to enrollment\nAmbulatory or require minimum support walking, per parent\nAble to sit still for 5 minutes or longer with a preferred toy item, per parent\nAdequate vision and hearing for the purposes of test administration, per parent\nAdequate arm-hand-finger coordination (i.e., able to point) for learning and cognitive tasks used in outcome measurement, per parent\nStable and controlled mental disorder\nUnder the care of a caregiver willing to participate by attending regularly scheduled appointments and completing the necessary measures\nNormal heavy metals test for lead and mercury levels performed within 30 days of first stem cell infusion\nMust provide name and specialty of specialist who has made Autism Spectrum Disorder (ASD) diagnosis\nAdequate financial means to cover $7,200 (US Dollars) plus travel expenses\n\nExclusion Criteria:\n\nSignificant prematurity at birth (less than 32 weeks gestation); or birth weight significantly below normal for gestational age (SGA - small for gestational age)\nmental retardation\nseizure disorder\nauto-immune conditions\nhistory of head trauma and other neurological or medical conditions\nAbnormal heavy metals test for lead and mercury performed within 30 days of first stem cell infusion\nPrior stem cell therapy of any kind",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "6 Years",
      "MaximumAge": "16 Years",
      "StdAgeList": {
        "StdAge": [
          "Child"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Nelson Novarro, MD",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Jorge Paz-Rodriguez, MD",
            "OverallOfficialAffiliation": "Translational Biosciences / Stem Cell Institute Panama",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Stem Cell Institute",
            "LocationCity": "Panama City",
            "LocationCountry": "Panama"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000001321",
            "ConditionMeshTerm": "Autistic Disorder"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000067877",
            "ConditionAncestorTerm": "Autism Spectrum Disorder"
          },
          {
            "ConditionAncestorId": "D000002659",
            "ConditionAncestorTerm": "Child Development Disorders, Pervasive"
          },
          {
            "ConditionAncestorId": "D000065886",
            "ConditionAncestorTerm": "Neurodevelopmental Disorders"
          },
          {
            "ConditionAncestorId": "D000001523",
            "ConditionAncestorTerm": "Mental Disorders"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M3775",
            "ConditionBrowseLeafName": "Autistic Disorder",
            "ConditionBrowseLeafAsFound": "Autism",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M206",
            "ConditionBrowseLeafName": "Autism Spectrum Disorder",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5055",
            "ConditionBrowseLeafName": "Child Development Disorders, Pervasive",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5054",
            "ConditionBrowseLeafName": "Developmental Disabilities",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M29797",
            "ConditionBrowseLeafName": "Neurodevelopmental Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3967",
            "ConditionBrowseLeafName": "Mental Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M13625",
            "ConditionBrowseLeafName": "Psychotic Disorders",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BXM",
            "ConditionBrowseBranchName": "Behaviors and Mental Disorders"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}